Boehringer Ingelheim Spring Co-Op Oncology Research in USA | Apply Now For Immune Regulation Role & Earn Upto $33 /hr

The Boehringer Ingelheim Co-Op Oncology Research opportunity is a Spring Co-Op role offering current MSc and PhD students hands-on experience in cancer immunology at the company’s Ridgefield, Connecticut facility. Working with the Immune Regulation team, the selected student will develop in vitro assays that recreate key suppressive features of the tumour microenvironment to support research into novel immunomodulatory therapeutics.

  • Position: Spring Co-Op, Oncology Research – Immune Regulation team

  • Location: Ridgefield, Connecticut, USA

  • Job ID: 38688

  • Category: Research – Oncology Research

About The Company

This opportunity is with BI Pharmaceuticals, Inc., within Boehringer Ingelheim’s Oncology Research department. The Immune Regulation team offers a multidisciplinary setting where the co-op student will collaborate with scientists on experimental approaches to understanding and restoring anti-tumour immunity.

Boehringer Ingelheim Co-Op Research Project

Solid tumours contain suppressive immune and stromal cells, soluble mediators and metabolic constraints that can inhibit immune responses. Conventional in vitro immune assays can measure immune cell activation but may not adequately reproduce these conditions.

For this Boehringer Ingelheim Co-Op, the project aims to establish functional immune suppression assays that mimic important components of the tumour microenvironment. These assays will provide translational platforms for evaluating potential therapeutics and investigating mechanisms that restore anti-tumour immunity.

The position is full-time and on-site in Ridgefield.

Duties and Responsibilities

  • Develop and refine tumour tissue dissociation protocols.

  • Develop immune suppression assays that mimic the tumour microenvironment.

  • Establish and optimise tumour cell killing assays.

  • Collaborate with scientists on in vitro cancer immunology experiments.

Academic Requirements

Applicants must:

  • Be current MSc or PhD students in good academic standing.

  • Remain enrolled at an accredited college or university throughout the co-op.

  • Have a major or minor in a related field, such as Immunology, Oncology or Cell Biology.

  • Have completed at least nine credit hours at their current college or university.

A GPA of at least 3.0 on a 4.0 scale is preferred.

Eligibility Requirements

  • Be at least 18 years old.

  • Be legally authorised to work in the United States without restriction.

  • Be willing to undergo a drug test and a post-offer physical examination if required.

Laboratory Experience and Desired Skills

Previous experience with cell line or primary cell culture is required, preferably involving cancer cells, T cells or myeloid cells.

Relevant skills and experience include:

  • Strong scientific understanding of, and interest in, immunology, oncology or cell biology.

  • Hands-on experience with FACS, ELISA/MSD and/or immune cell isolation.

  • Ability to troubleshoot experiments independently and collaboratively.

  • Strong scientific writing, record-keeping and oral communication.

  • Interest in working within a multidisciplinary team.

Experience with CRISPR validation and establishing in vitro systems, such as tumour cell killing assays, is an additional advantage.

Compensation and Benefits

  • Hourly pay: $24.00–$33.00, depending on the degree programme in which the applicant is enrolled.

  • Medical coverage.

  • Paid time off and paid holidays.

  • Disability and life insurance.

  • Other company-sponsored benefits.

No application deadline is stated.

The Boehringer Ingelheim Co-Op position in Spring Oncology Research offers MSc and PhD students with cell culture experience an opportunity to strengthen their experimental skills in cancer immunology. The project combines assay development, collaborative troubleshooting and research into the mechanisms that limit effective anti-tumour immune responses.

APPLY ONLINE HERE